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1. INTRODUCTION 
 
Arthritis is a form of joint disorder that involves inflammation of one or more 
joints, synovial tissue inflammation, associated with warm swollen and painful joints, 
it also affects the underlying bone and cartilage. It is a disabling and painful 
inflammatory condition, which can lead to substantial loss of mobility. The structures 
especially affected are joints, tendons, ligaments, bones and muscles. Arthritis 
affected 15% of people that is over 180 million people, in India.1 It is not a hereditary 
disease. It can develop at any age but most commonly occurs between the age of 40 
and 60. The most commonly affected joints are the small joints in the fingers, thumbs, 
wrists, feet and ankles. Pain medications, steroids and NSAID’s are frequently used to 
help with symptoms. Arthritis is one of those conditions on which billions of dollars 
are spent every year for the treatment and research. 
 
CAUSES FOR RHEUMATOID ARTHRITIS2 
 The causes for rheumatoid arthritis are not properly known. It’s an auto 
immune problem which means the body defence system start attacks its own joints 
and organs. Immune system mistakenly sends antibodies to the lining of your joints, it 
attack the tissues sourrounding the joints. This causes the thin layer of cells covering 
the joints to become sore and inflamed. Inflammation in the joints releases chemicals 
that thicken the synovium, it leads to gradually the loss of shape of joint and 
alignment and destroy the joints completely. Certain genes have been identified that 
increase the risk of rheumatoid arthritis. Hormonal changes and smoking increases the 
risk of developing rheumatoid arthritis. 
 
CLINICAL MANIFESTATION  
 The most common systemic manifestation of rheumatoid arthritis is anaemia, 
which occurs more frequently in the early stage of the disease. Additionally 
haemoglobin levels are inversely correlated with IL-6 levels. IL-6 levels are required 
for the induction of hepcidine during inflammation and rapidly induces hypoferraemia 
in humans. Release of TNF-α, IL-6 and IL-1 from synovial tissue, including adipose 
tissue, skeletal muscle, liver and the vascular endothelium. Rheumatoid arthritis 
related dyslipidaemia is characterized by low total and high-density lipoprotein 
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(HDL), cholesterol, elevated triglyceride and lipoprotein levels. It also associated with 
risk of future myocardial infarction. 
 
PATHOGENESIS AND PATHOPHYSIOLOGY3 
 The earliest event in rheumatoid arthritis pathogenesis is activation of the 
innate immune response, which includes the activation of dendritic cells by 
exogenous material and autologous antigens. Antigen presenting cells, including 
dendritic cells, macrophages and activated B cells, present arthritis-associated 
antigens to T cells. 
 
 Concurrently, CD4+ T cells that secrete IL-2 and IFN-Y infiltrate the synovial 
membrane. As noted previously, most patients with rheumatoid arthritis carry the 
epitope of the HLA-DR β-chain that confers binding of specific peptides and affects 
antigen presentation to TCRs. Disease associated HLA-DR alleles may present 
arthritis-related peptides, leading to stimulation and expansion of auto antigen specific 
T cells in the joints and lymph nodes. B cells contribute to rheumatoid arthritis 
pathogenesis not only through antigen presentation, but also through the production of 
antibodies, auto-antibodies and cytokines. RF and anti-CCP autoantibodies are 
common in patients with rheumatoid arthritis. B lymphocytes express cell surface 
proteins, including immunoglobulin and differentiation antigens such as CD20 and 
CD22. Autoantibodies can form larger immune complexes that can further stimulate 
the production of pro-inflammatory cytokines, including TNF-α, through complement 
and Fc-receptor activation. 
 
 T and B- cells activation result in increased production of cytokines and 
chemokine’s, leading to a feedback loop for additional T-cell, macrophage and B-cell 
interactions. In addition to antigen presentation, macrophages are involved in 
osteoclast genesis and are a major source of cytokines, including TNF-α, IL-1 and IL-
6. Within the synovial membrane there is a great increase in activated fibroblast-like 
synoviocytes, which also produce inflammatory cytokines, PGs and MMPs. 
Synoviocytes contribute to the destruction of cartilage and bone by secreting MMPs 
into the SF and by direct invasion into these tissues. 
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FIG NO: 1 PATHOGENESIS OF RHEUMATOID ARTHRITIS 
 
 
 
FIG NO: 2 SCHEMATIC REPRESENTATION OF RHEUMATOID 
ARTHRITIS 
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SIGNS AND SYMPTOMS4 
• Pain, swelling and stiffness of affected joints. The stiffness is usually worse in 
the morning. 
• Inflammation in the joints and sometimes in various organs of the body, such 
as the lungs, eyes etc,. 
• Morning stiffness that may last for hours 
• Pain spreads to the wrists, knees, ankles, elbows, hips and shoulders. 
• Erosions or periarticular osteopenia in hand or wrist joints. 
• Reduced ability to move the joint. 
• Redness of the skin around the joint during mornings. 
 
FIG NO: 3 NORMAL AND ARTHRITIC JOINT 
 
 
 
MANAGEMENT OF ARTHRITIS5 
 The focus of treatment for arthritis is to control pain, minimize joint damage 
and improve or maintain function and quality of life. According to the severity of 
disease the management of arthritis involves as follows, 
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 Medications  
 Non-pharmacologic therapies 
 Physical or occupational therapy 
 Splints or joint assistive aids 
 Weight loss 
 Surgery  
 
SYNTHETIC DRUGS FOR THE TREATMENT OF ARTHRITIS6 
The following types of drugs can be used to treat rheumatic diseases and related 
conditions.  
• Analgesics—pain relievers such as acetaminophen. 
• Topical analgesics—creams or ointments that are rubbed into the skin over 
sore muscles or joints to relieve pain. 
• Non-steroidal anti-inflammatory drugs (NSAIDs)—pain relievers such as 
Ibuprofen, Naproxen sodium and ketoprofen are available over the counter. 
Some NSAIDS are available only with a prescription.  
• Disease-modifying anti-rheumatic drugs (DMARDs)—a family of 
medicines used to treat conditions like rheumatoid arthritis and spondylitis. 
These drugs work by slowing or stopping the immune system from attacking 
the joints.  
• Hyaluronic acid substitutes—these medicines mimic a naturally occurring 
body substance that moistens joints to help them move better. Usually a 
person receives three to five injections directly into the affected knee or hip to 
help relieve pain and provide flexible joint movement.  
• Nutritional supplements—these products include S-adenosylmethionine 
(SAM-e) for osteoarthritis and fibromyalgia, dehydroepiandrosterone (DHEA) 
for lupus and glucosamine and chondroitin sulfate for osteoarthritis. Patients 
should read reports on how safe and effective a supplement is before taking it. 
Many have not been proven helpful in scientific studies. The U.S. Food and 
Drug Administration does not regulate supplements the way it monitors drugs.  
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HERBAL TREATMENT FOR ARTHRITIS7, 8 
Man was completely depending on the medicinal plants for the treatment of 
disease before the discovery of synthetic drugs. Alternative systems of medicine are 
still curing arthritis instead of treating symptoms. In an effort to gain relief and take a 
natural approach, more arthritis patients are seeking herbal remedies than ever before. 
Certain herbs may have anti-inflammatory properties that can help with rheumatoid 
arthritis, as well as the ability to reduce pain in all forms of the disease. 
 
SOME OF THE HERBS USED IN THE TREATMENT OF ARTHRITIS 
 
TABLE NO: 1 NATURAL HERBS FOR TREATING ARTHRITIS 
S.NO NATURAL HERBS FOR TREATING ARTHRITIS 
1. Aloe vera 
2. Boswellia 
3. Cat’s claw 
4. Eucalyptus 
5. Ginger 
6. Green tea 
7. Thunder god vine 
8. Turmeric 
9. Willow bark 
10. Clove 
11. Devils claw 
12. Psammosile 
13. Almonds 
14. Swertia chiraytia 
15. Nyctanthes arbor 
 
 Considering the importance of herbal medicine in the treatment of arthritis, the 
present study was aimed to identify a plant available abundantly in India which has 
the potential anti-arthritic agent for the treatment of arthritis. 
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REVIEW OF LITERATURE 
 
 A thorough literature survey was carried out in-order to identify the plant 
which is traditionally used in the treatment of arthritis. Among so many herbs 
available to treat arthritis. Sterculia foetida was selected for the present study because 
it is traditionally used to treat arthritis but not yet proven scientifically9, 10.  
Literature review of Sterculia foetida Linn., was carried out to find out the 
research work on this plant. The review of literature showed that many studies were 
done on different part of this plant. This review is made to confirm that anti-arthritic 
activity on the bark was not yet proven scientifically. Hence further studies were easy 
to carry out.  
 
PHARMACOGNOSTICAL REVIEW 
 Sonia Mitra et al., (2014) studied the taxonomic significance of petiole 
anatomy of Sterculiaceous species distributed in northeast India.11 
 Anitha et al., (2002) carried out the study on shoot regeneration from 
hypocotyl tip explants of Sterculia foetida Linn., derived from the seedlings.12 
 
PHYTOCHEMICAL REVIEW 
 Christie WW et al., (2014) studied the Fatty acids: Natural alicyclic, 
structures, occurrence and biochemistry.13 
 Kale SS et al., (2011) carried out the Analysis of fixed oil from Sterculia 
foetida Linn.,14 
 Niran Vipunngeum et al., (2009) studied the Fatty acids of Sterculia foetida 
seed oil.15 
 Xia P et al., (2009) studied the Chemical constituents from the leaves of 
Sterculia foetida Linn.,16 
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PHARMACOLOGICAL REVIEW 
 Ravichandran M et al., (2015) studied the In-vitro antioxidant, anticancer and 
phytochemical screening of Sengathari Thylum-A polyherbal siddha 
formulation.17 
 
 Shazia Hussain S et al., (2014) conducted  the preclinical of anti-diabetic and 
Anti-hyperlipidemic activity of methanolic extract of Sterculia foetida Linn., 
leaves by using Wistar albino rats.18 
 Raja TAR et al, (2014) carried out the  evaluation of anticonvulsant effect of 
Sterculia foetida (Pinari) in Pentylenetetrazole (PTZ) and maximal Electrical 
shock induced convulsions in albino rats.19 
 Shivakumar Singh P et al., (2014)  studied the anti-dermatophytic activity of 
low polar petroleum ether and inter polar methanolic extract of Sterculia 
foetida Linn.,20 
 Narsing Rao Galla et al., (2012) studied the In-vitro antioxidants activity of 
Sterculia foetida Linn., seed methanol extract.21 
 Pierangeli G et al., (2011) performed the antimicrobial activity, cytotoxicity 
and phytochemical screening of Ficus saptic Burn and Sterculia foetida 
Linn.,22 
 Majumdar AM, et al., (2011) conducted the Pharmacological studies on 
Sterculia foetida leaves.23 
 James Perfield et al., (2011) performed the study Plant oil may hold key to 
reducing obesity related medical issues.24 
 Usharani P et al, (2009) studied the Toxic and antifeedant activity of Sterculia 
foetida Linn., seed crude extract against Spodoptera litura F. and Achaea 
janata L.,25 
 Edward T et al, (1964) carried out the study on Delay of sexual maturity of the 
female rat.26 
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 Noamesi BK et al, (1986) carried out Preliminary report on the bronchodilator 
properties of the aqueous stem bark extract of Sterculia foetida.27 
 Scarpelli DG et al., (1974) studied the Mitogenic activity of sterculic acid, a 
cyclopropenoid fatty acid.28 
 
PHARMACEUTICAL REVIEW 
 Mahakalkar NG et al., (2013) carried out study of Zolmitriptan nasal In-situ 
gel using Sterculia foetida Linn., gum as natural muco-adhesive polymer.29 
 Bindhu CH et al., (2011)  Prepared and evaluation of bio-diesel from Sterculia 
foetida seed oil.30 
 Amit Ashok et al., (2008) carried out the Evaluation of Sterculia foetida gum 
as controlled release excipients.31 
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3. PLANT PROFILE32, 33 
 
Plant name   :      Sterculia foetida Linn., 
Common name  :      Wild Almond, Java Olive. 
Family    :      Sterculiaceae 
 
VERNACULAR NAMES 
• Tamil  - Kutiraippitukkan,  
• Bengali - Jungli Badam  
• Hindhi  - Jangli Badam 
• Kannada - Bhatala Penari,  
• Konkani - Kuvem ruk,  
• Malayalam - Pinar, 
• Marathi - Punava,  
• Telugu  - Adavibadamu,  
• Sanskrit - Putidaru. 
 
TAXONOMICAL STATUS 
• Kingdom   : Plantae 
• Sub Kingdom   : Tracheophyta 
• Division   : Mangoliophyta 
• Class   :      Magnoliopsida 
• Sub class   : Dilleniidae 
• Order   : Malvales 
• Family   : Sterculiaceae 
• Genus   : Sterculia 
• Species  : foetida 
 
HABITAT : East Asia-India, Sri-Lanka, Myanmar and Thailand. 
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FIG NO: 4 ENTIRE PLANT OF Sterculia foetida Linn., 
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PLANT DESCRIPTIONS34, 35 
TABLE NO: 2 PLANT DESCRIPTIONS 
S.NO PARTS IMAGES DESCRIPTION CHEMICAL CONSTITUENTS USES 
1. Leaves 
 
7-9 leaflets(crowded) of 
10-17cm long, petiole 
12.5-23cm long 
Procyanidin, scutellarein and 
luteolin and also consists, of 
taraxerol, n-otacosanol and 
beta-sitosterol 
Aperient, diuretic, 
abortifacient, skin disease, 
anti-diabetic activity, anti-
convulsant, antioxidant, anti-
cancer activity, CNS 
depressant and anti-
inflammatory activity. 
2. Seed 
 
ovoid-oblong, black 
Cyclopropene fatty acids- 
Sterculic acid and Malvalic 
acids 
Seed oil-skin disease and 
rheumatism. 
3. Bark 
 
Smooth and grey, 
Thickness 2.5-3cm, 
fibrous in nature 
Secutellarin, betulin, lupeol 
and betullic acid. 
Rheumatism, broncho dilator, 
diaphoretic and diuretic. 
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S.NO PARTS IMAGES DESCRIPTION CHEMICAL CONSTITUENTS USES 
4. Root 
 
Thick, brown in colour 
Leucoanthocyanidin-3-alpha-
L-rhamnopyranoside and 
quercetin and rhamnoside. 
Anti-inflammatory. 
5. Flower 
 
Reddish orange in 
colour Contains fatty acids - 
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4. RATIONALE FOR SELECTION OF THE PLANT 
 
 Arthritis is a chronic disease which affects 15% of the people in India. The 
research work is decided to study the herbal plant drug which cures arthritis and 
reduces side effects.  
 
 Traditionally, Sterculia foetida is used in the treatment of various disorders by 
the traditional healers it is also used as aperient, diuretic, abortifacient, skin disease, 
anti-diabetic activity, anti-convulsant, antioxidant, CNS depressant and anti-
inflammatory activity.  
 
 The bark has a claim to treat arthritis which is not proven scientifically. Hence 
the present work was under taken to establish the effects of Sterculia foetida bark in 
the treatment of arthritis.  
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5. AIM AND OBJECTIVE 
 
AIM 
 To evaluate the Pharmacognostical, Phytochemical and Anti-arthritic activity 
on the bark of Sterculia foetida Linn.,  
 
OBJECTIVE 
 
Pharmacognostical studies: Establishment of Pharmacognostical standards for the 
bark of Sterculia foetida Linn., 
 
Phytochemical studies: To determine the phytochemical constituents and to isolate 
and identify the biomarkers present in the plant  
 
Pharmacological studies 
 To select the active extract by in-vitro anti-arthritic  and anti-oxidant studies 
 To evaluate in-vivo anti-arthritic activity on the bark of Sterculia foetida Linn., 
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PLAN OF WORK 
 
1. COLLECTION OF PLANT MATERIAL 
2. AUTHENTICATION 
3. PHARMACOGNOSTICAL STUDIES 
 Macroscopy 
 Microscopy 
• Histochemical studies 
• Powder microscopy 
• Quantitative microscopy – Linear measurement 
 Physiochemical constants 
 
4. PHYTOCHEMICAL STUDIES 
 Preparation of extracts 
 Preliminary phytochemical analysis 
 Quantitative estimation of phytoconstituents 
 Fluorescence analysis 
 Thin layer chromatography 
 High performance thin layer chromatography 
 
5. SELECTION OF ACTIVE EXTRACT 
 In-vitro anti-oxidant activity 
 DPPH Assay  
 Nitric oxide scavenging assay 
 In-vitro anti-arthritic activity 
 Protein Denaturation Method 
 
6. ACUTE TOXICITY STUDIES 
7. IN-VIVO ANTI-ARTHRITIC ACTIVITY 
8. ISOLATION AND IDENTIFICATION OF BIOLOGICAL MARKER 
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6. PHARMACOGNOSTICAL STUDIES 
6.1. MATERIAL AND METHODS 
COLLECTION OF PLANT MATERIAL  
 The fresh healthy bark of Sterculia foetida Linn., was collected in the month 
of June at Madras Medical College, Chennai 03 
 
AUTHENTICATION OF THE PLANT BARK 
The plant material was authenticated by Dr. D. Aravind. M.D.(S), Msc. 
Assistant Professor,  Medicinal Plants, National Institute of Siddha (Govt. of India), 
Tambaram. A voucher specimen (voucher specimen no: 10) is deposited in the 
Department of Pharmacognosy, Madras Medical College, Chennai. 
 
MACROSCOPIC EVALUATION 
 Various organoleptic characters like colour, odour, taste and nature of the bark 
like its size, shape, surface, fracture and thickness were observed for the 
determination of safety, efficacy and purity of crude drugs.  
 
MICROSCOPIC EVALUATION36-39 
Fixation of bark 
The bark was cut and fixed in FAA solution (Formalin 5ml + Acetic acid 5ml 
+ 90ml of 70% Ethanol). The specimen was dehydrated after 24 hours of fixing. The 
bark was graded with series of tertiary butyl alcohol, as per the standard procedure. 
 
 It was carried out by gradual addition of 58 – 60º C of melting pointed paraffin 
wax until Tertiary butyl alcohol (TBA) solution attained super saturation. The 
specimens were cast into paraffin blocks. 
 
The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10 - 12µ. De-waxing of the sections 
was done by customary procedures. The sections were stained with haematoxilin. The 
stained sections were viewed under microscope. 
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Photomicrographs  
Microscopic descriptions of tissues were supplemented with photo 
micrographs whenever necessary. Photo micrographs of section were taken at 
different magnification for focusing of different microscopical parts of the bark. 
 
POWDER MICROSCOPY40, 41 
The shade dried bark was powdered and used for powder microscopic 
analysis. The organoleptic characters were observed and to identify the different 
microscopical characteristic features various staining reagent were used. Powder was 
stained with 1% phloroglucinol in 90% ethanol, concentrated hydrochloric acid and 
observed under microscope. Powder analysis is used for the detection of characteristic 
structures and various cell components. 
 
HISTOCHEMICAL COLOR REACTIONS42 
The transverse sections of bark were stained with different staining reagent 
such as Phluoroglucinol, Iodine, Ferric chloride, Dragendroff’s reagent, toluidine blue 
and Picric acid to observe and localize the presence of lignin contents, starch, tannins 
alkaloids, flavonoids and proteins as per the standard procedure. The stained sections 
were then washed in water to remove the excess stain and observed under a 
microscope. 
 
QUANTITATIVE MICROSCOPY43 
LINEAR MEASUREMENTS OF FIBRES 
 The length and width of the fibers present in the bark were observed under 
microscope.  This quantitative analysis will be helpful in the identification of the 
drug. 
 
The first step involved in this is calibration of the eyepiece micrometer using 
the stage micrometer. For determining the calibration factor, the eyepiece is removed 
from the microscope, then the lens is unscrewed and in the ridge the eyepieces 
micrometer is placed. The lens is then replaced. The stage micrometer is then placed 
on the stage of the microscope and focused under high power with the eyepiece 
coincides with each division of stage micrometer and calculate the calibration factor 
using the standard formula. 
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The stage micrometer is replaced with the slide containing the powdered drug. 
The slide is prepared by using the bark powder on a slide is treated with a drop of 
phloroglucinol and conc. Hydrochloric acid and viewed under microscope. The width 
and length of fibers is measured by focusing them on the lines of the eyepiece 
micrometer. Note the no. of divisions covered by the length and width of the fibers. 
 
PHYSIOCHEMICAL ANALYSIS43-45 
 The shade dried powdered bark of Sterculia foetida Linn., was used for the 
analysis of various physiochemical parameters which is useful in the determination of  
quality and purity of crude drugs. Total ash, extractive values, loss on drying, foaming 
index, swelling index and foreign organic matters were determined as per the standard 
WHO guidelines which is very much useful in the determination of quality and purity 
of the crude drugs. 
 
DETERMINATION OF ASH VALUES 
The residue remaining after incineration is the ash content of the drug, which 
simply represents the inorganic salts naturally occurring in the drug or adhering to it 
or deliberately added to it as a form of adulteration. 
 
TOTAL ASH 
Silica crucible was heated to red hot for 30 minutes and it was allowed to cool 
in desiccators. About 2gm of powdered sample was weighed accurately and evenly 
distributed in the crucible. Dried at 100 – 105ºC for 1 hour and ignited to constant 
weight in a muffle furnace at 600±25ºC. The crucible was allowed to cool in a 
desiccator. The percentage yield of ash with reference to the air dried substance was 
then calculated by the formula 
 
Water soluble ash 
The total ash was boiled for 5min with 25ml of water. The insoluble matter 
was then collected in an ash less filter paper. It was washed with hot water and ignited 
for 15min at a temperature not exceeding 450ºC. The weight of the insoluble matter 
was subtracted from the weight of the ash and the difference in weight represented the 
 Pharmacognostical Studies 
 
Department of Pharmacognosy , MMC. Page 20 
 
water soluble ash, the percentage of water soluble ash with reference to the air dried 
substances was calculated with reference to the air dried material.  
 
Acid insoluble ash 
Acid insoluble ash is the residue obtained after boiling the total ash with dilute 
hydrochloric acid, and igniting the remaining insoluble matter. This measures the 
amount of silica present, especially as sand and siliceous earth 
 
Procedure 
To the total ash obtained previously, 25ml of dilute hydrochloric acid was 
added, covered with a watch glass and boiled gently for 5min on a burner. The watch 
glass was rinsed with 5ml of hot water and these washings were added to the crucible. 
The insoluble matter was collected on an ash less filter paper by filtration and the 
filter paper was rinsed repeatedly with hot water until the filtrate is neutral and free 
from acid. Filter paper containing the insoluble matter was transferred to the crucible, 
dried on a hot plate and ignited to a constant weight in the muffle furnace at 450-
500ºC. The silica crucible was removed from the muffle furnace and allowed to cool 
in a desiccator for 30min, and then weighed without delay. The content of acid 
insoluble ash was calculated 
 
Sulphated ash 
About 3gm of air-dried substance was ignited gently at first in a crucible, until 
the substance was thoroughly charred. Then the residue was cooled, moistened with 
1ml of  sulphuric acid, heated gently until the white fumes were no longer evolved 
and ignited at 800 ± 25ºC, until all the black particles were disappeared. The crucible 
was allowed to cool, a few drops of sulphuric acid was added and heated. Then it was 
ignited as before, cooled and weighed. The percentage of sulphated ash with reference 
to the air- dried substance was then calculated. 
 
DETERMINATION OF EXTRACTIVE VALUES 
This method is used to determine the amount of active constituents in a given 
amount of plant material when extracted with solvents. Extractive values are useful 
for the evaluation of phytoconstituents especially when the constituents of a drug 
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cannot be readily estimated by any other means. Further these values indicate the 
nature of the active constituents present in a crude drug. 
 
Determination of water soluble extractive 
About  5gm of the powder was weighed and macerated with 100ml of 
chloroform water (95ml distilled water and 5ml chloroform) in a closed flask for 24 
hours. It was shaken frequently for six hours and allowed to stand for eighteen hours. 
It was then filtered rapidly, taking precautions against loss of solvent and 25ml of the 
filtrate was evaporated to dryness in a tarred flat bottomed shallow dish. 2 ml of 
alcohol was added to the residue and it was dried at 105ºCfor 1 hour in the hot air 
oven and cooled in desiccators for 30min and weighed. The process was repeated till 
a constant weight was obtained; the percentage of water soluble extractive value with 
reference to the air dried drug was calculated. 
 
Determination of alcohol soluble extractive 
The alcohol soluble extractive value is also indicative for the same purpose as 
water soluble extractive value. The solvent strength of alcohol varies from 20-
90%v/v. The solvent strength has to be chosen depending upon the strength of alcohol 
used for the extraction of powdered drug. 
 
Procedure  
About 5gm of the powder was weighed and macerated with 100ml 90% 
ethanol in a closed flask for 24 hours. It was shaken frequently for six hours and 
allowed to stand for eighteen hours. It was then filtered rapidly, taking precautions 
against loss of solvent and 25ml of the filtrate was evaporated to dryness in a tarred 
flat bottomed shallow dish. It was dried at 105ºC for 1hour in a hot air oven. The dish 
was cooled in desiccator and weighed. The process was repeated till the constant 
weight was obtained. The percentage of alcohol soluble extractive value with 
reference to the air dried drug was calculated. 
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Determination of non-volatile ether soluble extractive (fixed oil content) 
Accurately weighed quantity of the drug was transferred to an extraction 
thimble and extracted with solvent ether or petroleum ether (Boiling Point 40 - 60ºC) 
in a Soxhlet for 6 hours. The extract was filtered into a tarred evaporating dish, 
evaporated and dried at 105°C to constant weight. The percentage of non-volatile 
ether soluble extractive value with reference to the air dried drug was calculated. 
 
Determination of volatile ether soluble extractive 
About 2gm of powdered drug was accurately weighed and extracted with 
anhydrous diethyl ether in a continuous extractive apparatus for 20hours. The ether 
solution was transferred to tarred porcelain dish and evaporated spontaneously. Then 
it was dried over phosphorous pentoxide for 18hours and the total ether extract was 
weighed. The extract was heated gradually and dried at 105ºCto constant weight. The 
loss in weight represents the volatile portion of the extract. 
 
LOSS ON DRYING 
Accurately weighed quantity of the substances was taken in a previously 
ignited and cooled silica crucible and the substance was evenly distributed by gentle 
side wise shaking. The crucible with the contents was weighed accurately. The loaded 
crucible and the lid were placed in the drying chamber (105ºC). The substance was 
heated for a specified period of time to a constant weight. The crucible was covered 
with the lid and allowed to cool in a desiccator at room temperature before weighing. 
Finally the crucible was weighed to calculate the loss on drying with reference to the 
air dried substance. 
 
DETERMINATION OF FOAMING INDEX 
About 1gm of the coarsely powdered drug was weighed and transferred to 
500ml conical flask containing 100ml boiling water. The flask was maintained at 
temperature 80-90ºC for about 30min. It was then cooled and filtered into a 
volumetric flask and sufficient water was added through the filtrate to make up the 
volume to 100ml. The decoction was poured into 10 stopper test tube (height 16cm, 
diameter 16mm) in successive portions of 1ml, 2ml, 3ml, 4ml up to 10ml and the 
volume of the liquid in each tube was adjusted with water to 10ml. The tubes were 
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stoppered and shaked in a length wise motion for 15 seconds, two shakes per second. 
Allowed to stand for 15min and the height of the foam were measured. The results are 
assessed as follows: if the height of the foam in every tube is less than 1cm, the 
foaming index is less than   100. If a height of 1cm is measured in any tube, the 
volume of the plant material decoction in the tube (a) is used to determine the index. 
If this tube is the first or second tube in a series, prepare an intermediate dilution in a 
similar manner to obtain a more precise result. The height of the foam is more than 
1cm in every tube the foaming index is over 1000. In this case repeat the 
determination using a new series of dilution of the decoction in order to obtain a 
result. Calculate the foaming index using the following formula. 
 
Foaming index = 1000/a 
 
Where, a is the volume in ml of the decoction used for preparing the dilution in the 
tube where foaming to a height of 1cm is observed. 
DETERMINATION OF SWELLING INDEX 
The swelling index is the volume in ml occupied by the swelling of 1gm of 
plant material under specified conditions.  
 
Procedure  
A specified quantity of the plant material was accurately weighed and 
transferred into a 25ml glass stoppered measuring cylinder. The internal diameter of 
the cylinder should be about 16mm, the length of the graduated portion about 125mm, 
marked in 0.2ml divisions from 0 to 25ml in an upward direction. Unless otherwise 
indicated in the test procedure, add 25ml of water and shake the mixture thoroughly 
every 10min for 1hour, allowed to stand for 3 hours at room temperature. The volume 
in ml occupied by the plant material was measured including any sticky mucilage. 
Calculate the mean value of the individual determination, related to 1gm of plant 
material. 
FOREIGN ORGANIC MATTER 
 The weighed quantity of bark powder was examined for the determination of 
foreign organic matter by inspection with the use of lens and calculated. 
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6.2. RESULTS AND DISCUSSION 
The results of pharmacognostical studies are as follows. 
 
MACROSCOPICAL STUDIES        
Organoleptic evaluation 
Colour  -    Grey 
Taste  -    Bitter 
Odour  -    Odourless 
Texture -    Smooth 
 
Morphological evaluation 
Appearance -    Outer bark is smooth grey in colour 
 Inner bark is fibrous brown in colour 
Shape  -    Single quill 
Length  -    13-15cm 
Thickness -     2.5-3cm              
Fracture -     Fibrous 
 
  
FIG NO: 5 & 6 MORPHOLOGY OF THE BARK OF  
Sterculia foetida Linn., 
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MICROSCOPY OF BARK  
The transverse section of bark of Sterculia foetida Linn., showed different types of 
cells. Cork cells, cortex, cork cambium, sclerenchyma, endodermis, phloem cells, 
calcium oxalate crystals, medullary rays, pericyclic fibres were observed.  These 
characters are observed in different magnification lenses.  The following characters 
were seen and reported by photographically. 
 
 
FIG NO: 7 ENTIRE TRANSVERSE SECTION OF BARK (4X) 
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Cork 
 It consists of 10-15 layers of rectangular, regularly arranged  cells in radial 
rows and have some reddish brown contents. 
 
Cortex                                                                                         
It consists of parenchyma cells in which scattered sclereids either isolated or in 
groups. 
 
Medullary rays 
It consists of parenchymatous cells run diagonally and extent from 
pith(medulla) to cortex through secondary xylem and secondary phloem. Width of the 
rays are 4-5 cells(multiseriate) wavy. 
 
Phloem fibers 
 It is small, lignified and polygonal in shape. 
 
Sclerenchymatous cells 
 The sclereids are which are lignified and pitted. Inner and radial walls of the 
sclereids are more thicker than the outerwalls and appears as U shape. 
 
Calcium oxalate crystals 
 Prism like calcium oxalate crystals are observed in the cortical sclerenchyma.  
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ENLARGED MICROSCOPY OF BARK 
 
 
 
 
 
      FIG NO: 8 CORK ENLARGED   FIG NO: 9 CORTEX ENLARGED 
  
FIGNO: 10 MEDULLARY RAYS 
ENLARGED 
FIG NO: 11 PHLOEM FIBRES 
ENLARGED 
 
 
FIG NO: 12 
SCLERENCHYMAENLARGED 
FIG NO: 13 CALCIUM OXALATE 
CRYSTALENLARGED 
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HISTOCHEMICAL COLOUR REACTIONS 
 Transverse section of bark of Sterculia foetida Linn., was treated with various 
reagents like Dragendroff’s reagent, N/50 iodine, phloroglucinol and Conc. HCl, 
ferric chloride, picric acid and toludine blue. The histochemical color rections of 
transeverse section of bark showed different stainined cells were observed. These 
characterisitic features were observed and reported in the table no:3 
 
Table no: 3 Histochemical colour reactions of Sterculia foetida Linn., 
S. No Chemicals Test for Nature of 
change Histology 
Degree 
of 
change 
1 Phloroglucinol + HCl Lignin 
Dark 
yellow 
In the cortex 
region + 
2 N / 50 Iodine 
solution Starch Black In the Cortex + 
3 Dil. Ferric 
chloride Tannin 
Bluish 
green 
Phloem 
Parenchyma + 
4 Dragendorff’s Reagent Alkaloid Brown Outer cortex + 
5 Picric acid Protein Intense yellow Phloem + 
6 Toluidine blue Flavonoids Bluish green Cortex region + 
 
Note:    +  - Indicates the presence and absence  
 
The histochemical analysis on the bark of Sterculia foetida Linn., showed the 
presence of alkaloids, starch grains, lignin, flavonoids are localized in the cortex 
region, proteins and tannins are localized in phloem region. 
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HISTOCHEMICAL STUDIES 
 
 
 
FIG NO: 14 Localization of Lignin 
(Pink) in cortex 
FIG NO: 15 Localization of Starch 
grains (Black) in cortex 
  
FIG NO:16 Localization of  Tannins 
(Bluish green) in phloem parenchyma 
FIG NO:17 Localization of Alkaloid 
(Brown) in outer cortex 
 
 
FIG NO:18 Localization of Protein 
(Intense yellow) in phloem cells                
 
FIG NO:19 Localization of Flavonoid 
(Bluish green) in cortex 
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POWDER MICROSCOPY 
ORGANOLEPTIC CHARACTERS 
 Nature  : Coarse powder 
 Colour  : Buff colour 
 Odour   : Characteristic odour 
 Taste   : Bitter taste 
 
            The powdered bark of Sterculia foetida under microscopic investigation 
showed the presence of lignified fibres, xylem, sclereids, phloem fibres, 
parenchymatous cells and calcium oxalate crystals.  
 
Fibres 
 Fibres are lignified and scattered. 
 
Phloem fibres 
 Phloem fibres occur lengthwise in groups of 3-5 cells, the brown masses are 
adhering to the fibres.  
 
Calcium oxalate crystals. 
Prismatic and rosette type calcium oxalate crystals in the cortical parenchyma 
and as well free in the powder are seen. 
 
Cork  
 Occasional fragments of cork with thin walled cells, polygonal surface view 
and containing brownish matter. 
 
Sclereids (or) stone cells 
Scleredis which are ovoid to irregular in shape and yellowish in colour, 
(appears as ‘U’ shaped as one wall is thick than other). 
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POWDER MICROSCOPY 
 
 
FIG NO: 20 FIBERS FIG NO: 21 SCLEREIDS 
FIG NO: 22 CALCIUM OXALATE 
CRYSTALS 
FIG NO: 23 PHLOEM FIBRES 
 
FIG NO: 24 CORK 
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QUANTITATIVE MICROSCOPY 
Linear measurement of fibres 
 The length and width of the fibres were measured in the powdered bark of 
Sterculia foetida Linn., and the results were shown in  table no: 4. 
TABLE NO: 4 LINEAR MEASUREMENT OF FIBERS 
Dimension Minimum (µm) Average (µm) Maximum (µm) 
Length 365 423 531.2 
Width 49.8 54.78 66.4 
 
The length of the fibers were in the range of 365µm - 423 µm and the width of 
the fibers was found in the range of 49.8 µm – 54.78 µm. 
PHYSIOHEMICAL CONSTANTS 
 Physiochemical constants like total ash values, acid insoluble ash, water 
soluble ash, extractive values, loss on drying, swelling index, foaming index, foreign 
organic matter were studied and reported in table no: 5. 
TABLE NO: 5 PHYSIOHEMICAL ANALYSIS OF THE BARK OF 
Sterculia foetida Linn., 
S.NO PHYSIO-CHEMICAL CONSTANTS RESULTS (%W/W) 
I ASH VALUE 
1. Total ash 18.50±0.16 
2. Water soluble ash 8.26±0.75 
3. Acid insoluble ash 3.69±0.33 
4. Sulphated ash 11.68±0.36 
II EXTRACTIVE VALUE 
1. Water soluble extractive 3.56±0.42 
2. Alcohol soluble extractive 6.89±0.53 
3. Ether soluble extractive 5.63±0.21 
4. Non-volatile ether soluble extractive 4.64±0.52 
III Loss on drying 1.88±0.50 
IV Foaming index Nil 
V Swelling index Nil 
VI Foreign organic matter 0.96±0.54 
Values are expressed as Mean ± SD, n=3 
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The foreign organic matter of bark of Sterculia foetida Linn., was found to be 
0.96±0.54% w/w. The total ash, acid insoluble ash, water soluble ash and sulphated 
ash were found to be 18.50±0.16% w/w, 3.69±0.33% w/w, 8.26±0.75% w/w and 
11.68±0.36% w/w respectively. The water soluble extractive, alcohol soluble 
extractive, ether soluble extractive, and non-volatile extractive values were found to 
be 3.56±0.42% w/w, 6.89±0.53% w/w, 5.63±0.21% w/w, 4.64±0.52% w/w 
respectively. Loss on drying was found to be 1.88±0.50% w/w. The foaming index 
and swelling index was found to be nil this indicates the absence of mucilage and 
saponins. 
 
This detailed Pharmacognostical investigation on the bark of Sterculia foetida 
Linn., will be useful for the identification of the drug in crude as well as powder form 
in order to differentiate the plant from its allied species and adulterants.  
 
  
 
Phytochemical studies 
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7. PHYTOCHEMICAL STUDIES 
 
7.1. MATERIAL AND METHODS 
Phytochemical evaluation is used to determine the nature of phytoconstituents 
present in the plant by using suitable chemical tests. Phytochemical analysis is very 
much important because the therapeutic activity is based on the constituent present in 
the drug. It can be done by confirmation with different chromatographic techniques 
like TLC and HPTLC. Therefore a complete investigation is required to characterize 
the Phytoconstituents qualitatively and quantitatively. 
 
PREPARATION OF EXTRACTS 
Fresh bark was collected, dried in shade, coarsely powdered and successively 
extracted with solvents of increasing polarity like n-hexane, chloroform, ethyl acetate 
and ethanol by continuous percolation process using soxhlet apparatus. After 
extraction each extracts were concentrated by using rotary vacuum evaporator. It is 
dried and the percentage yield was calculated. Appearance and consistency of the 
extract were also noted. 
 
PRELIMINARY PHYTOCHEMICAL SCREENING46-48 
The bark powder and extracts were subjected to qualitative chemical analysis 
for the identification of active constituents in each extracts and the powdered bark. 
 
DETECTION OF ALKALOIDS 
Dragendorff’s reagent 
 To the sample 5ml of 2M HCl was added. Then 1ml of Dragendorff’s reagent 
was added and examined for an immediate formation of an orange red precipitate. 
 
Mayer’s reagent  
To the substance little quantity of dilute hydrochloric acid and Mayer’s 
reagent were added and examined for the formation of white precipitate. 
 
Wagner’s reagent 
The test substance was treated with little amount of Wagner’s reagent and 
examined for the formation of reddish brown precipitate. 
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DETECTION OF GLYCOSIDES 
Borntrager’s test 
The powdered material was boiled with 1ml of sulphuric acid in a test tube for 
five minutes. Filtered while hot, cooled and shaken with equal volume of chloroform. 
The lower layer of solvent was separated and shaken with half of its volume of dilute 
ammonia. A rose pink to red colour is produced in the ammonical layer indicates the 
presence of anthroquinone glycosides. 
 
Modified Borntrager’s test 
The test material was boiled with 2ml of the dilute sulphuric acid. This was 
treated with 2ml of 5% aqueous ferric chloride solution (freshly prepared) for 5 
minutes, and shaken with equal volume of chloroform. The lower layer of solvent was 
separated and shaken with half of its volume of dilute ammonia. A rose pink to red 
colour is produced in the ammonical layer. 
 
Legal’s test 
 The test sample when treated with sodium nitropruside in pyridine and 
methanolic alkali. Formation of a pink red colour indicates the presence of cardiac 
glycosides. 
 
DETECTION OF STEROIDS AND TRITERPENOIDS 
LibermannBurchards Test  
 The powdered drug was treated with few drops of acetic anhydride, boiled and 
cooled. Conc.sulphuric acid was added from the sides of the test tube formation of 
brown ring is formed at the junction of two layers and upper layer turns green which 
shows presence of steroids and formation of deep red color indicates presence of tri 
terpenoids. 
 
Salkowski Test 
The extract was treated with few drops of concentrated sulphuric acid, red 
color at lower layer indicates presence of steroids and formation of yellow colored 
lower layer indicates presence of tri terpenoids. 
  
 Phytochemical Studies 
 
Department of Pharmacognosy , MMC. Page 36 
 
DETECTION OF FLAVONOIDS 
Shinoda’s test  
Small quantity of extract was dissolved in alcohol to this pieces to magnesium 
followed by concentrated hydrochloric acid were added drop wise and heated. 
Appearance of magenta colour shows the presence of flavonoids. 
 
Alkaline reagent test 
Small quantity of the extract was dissolved in aqueous sodium hydroxide and 
appearance of yellow colour indicates the presence of flavonoids. 
 
DETECTION OF CARBOHYDRATES 
Molisch’s test 
To the test solution few drops of alcoholic alpha napthol and few drops of 
conc. sulphuric acid were added through the sides of test tube, purple to violet color 
ring appears at the junction indicates the presence of carbohydrates. 
 
Fehling’s test  
The test solution was mixed with Fehling’s I and II, heated and examined for 
the appearance of red coloration for the presence of sugar. 
 
DETECTION OF TANNINS 
Lead acetate test  
The test solution was mixed with basic lead acetate solution and examined for 
formation of a white precipitate. 
 
Ferric chloride test  
 A few drops of 5% aqueous ferric chloride solution was added to 2ml of an 
aqueous extract of the drug and examined for the appearance of bluish black color. 
 
DETECTION OF PROTEINS 
Biuret test 
The sample was treated with 5-8 drops of 10% w/w copper sulphate solution 
and observed for the presence of violet color. 
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DETECTION OF SAPONINS 
A drop of sodium bicarbonate solution was added to the sample and the 
mixture was shaken vigorously and left for 3 minutes. Development of any honey 
comb like froth was examined. 
 
DECTECTION OF GUMS AND MUCILAGE 
The small quantities of test substance were dissolved in 5 to 10ml of acetic 
anhydride by means of heat, cooled and added 0.05ml of conc. sulphuric acid. 
Formation of bright purplish red color indicates the presence of gums and mucilage. 
 
DETECTION OF FIXED OILS AND FATS 
Small quantities of extracts were pressed between two filter papers. An oily 
stain on the filter paper indicates the presence of fixed oils and fats. 
 
QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
ESTIMATION OF ALKALOID CONTENT49-51 
Mobile phase 
About 9.93 g of monobasic potassium phosphate was dissolved in 730 mL of 
distilled water. Added 270 mL of acetonitrile, mixed, filtered, and degased.  
 
Standard solution 
 About 0.2mg of standard is accurately weighed and dissolved in a mixture of 
water and methanol in the ratio of 1 : 1. 
 
Test solution 
1gm of finely powder sample was transferred to a continuous-extraction 
apparatus with a 500-mL round-bottom flask. Treated with 150 mL of methanol and 
extracted for 6 hours, or until the solvent is clear. The volume of the thimble should 
be at least one-half that of the volume of methanol. Cooled to room temperature, and 
transferred the methanol extract to a 200-mL volumetric flask. Rinsed the extract unit 
with methanol, quantitatively transferred the contents to the volumetric flask and 
diluted with methanol to volume. 
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Method 
 This HPLC method was applied in the validation of the ambient extraction 
method. 
 
Chromatographic system  
The liquid chromatography is equipped with a 235-nm detector and a 4.6-mm 
×150-mm column that contains packing L1.The flow rate is about 1.8 mL per minute.  
 
Procedure 
Separately equal volumes (about 10 µL) of the Standard solution and the Test 
solution was injected into the chromatograph, recorded the chromatograms, and areas 
of the major peaks was measured. Calculate the percentage of alkaloids present in the 
solution using the formula.                                          
 
    100(CV/W) (r U / r S), 
Where,  
C - the concentration in mg per mL, Reference Standard in the  Standard solution 
using the correction factors as noted above, 
V - the final volume in mL of the  Test solution, 
W - the weight in mg  
rU and  rS are the peak areas from the  Test solution and the  Standard solution. 
 
ESTIMATION OF FLAVONOID CONTENT52-54 
Extraction solvent— mixture of alcohol, water and hydrochloric acid (50:20:8). 
Mobile phase 
Mixture of methanol, water, and phosphoric acid (100:100:1).  
 
Standard solutions 
 Transfer accurately weighed quantities of  USP Quercetin RS, kaempferol and 
iso-rhamnetin to separate volumetric flasks, dissolve each in methanol, and diluted 
quantitatively and stepwise if necessary, with methanol to obtain  Standard solutions 1 
mg per mL, respectively. 
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Test solution 
 Accurately weighed about 10.0 g of sample was transferred to a 250-mL flask 
fitted with a reflux condenser. Added 78 mL of Extraction solvent, and reflux on a hot 
water bath for 135 minutes cooled at room temperature and decanted to a 100-mL 
volumetric flask. 20 mL of methanol was added and sonicated for 30 minutes. Filtered 
and collected the filtrate in the 100-mL volumetric flask washed the residue on the 
filter with methanol and collected the washing in the same 100-mL volumetric flask. 
 
Chromatographic system   
The liquid chromatography is equipped with a 270-nm detector and a 4.6-mm 
× 25-cm column that contains packing L1. The flow rate is about 1.5 mL per minute.  
 
Procedure 
Separately injected equal volumes (about 20 µL) of each of the Standard 
solutions and the test solution into the chromatography, record the chromatograms 
and measured the areas for the major peaks. Calculated the percentage of flavonoid 
present in each sample. 
 
ESTIMATION OF STEROIDS55 
Standard solution 
 Weighed accurately a suitable quantity of the reference substance specified in 
the individual monograph, previously dried under the conditions specified in the 
monograph and dissolve in a suitable volume of aldehyde - free ethanol. Dilute 
quantitatively and stepwise with aldehyde - free ethanol to obtain a solution 
containing about 10g of the steroid per ml. 
 
Test Solution 
It is prepared by dissolving in a extraction solvent and made up to the volume 
in a standard flask. 
 
Method 
Into a glass - stoppered, 50 ml, conical flask and 20.0 ml of the test solution 
was taken. Into two similar flasks pipetted 20.0 ml of the standard solution and 20.0 
ml of aldehyde - free ethanol (Blank) respectively. To each flask 2.0 ml of blue 
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tetrazolium solution was added and mixed to each flask add 2.0 ml of the mixture of 
10 volumes of tetramethylammonium hydroxide solution (10%) and 90 volumes of 
aldehyde - free ethanol was added, mixed and allowed to stand in the dark a 
temperature between 25 and 35. At the end of exactly 90 minutes add to each flask 1.0 
ml of glacial acetic acid was added and mixed. Measure the absorbance’s of the 
solutions obtained from the test solution and the standard solution at about 525 nm 
against the blank. The quantity in mg, of the steroid in the 20-ml aliquot of the test 
solution is given by the expression 
 
At / As X Cs 
Where, 
At = absorbance of the test solution 
As = absorbance of the standard solution 
Cs = quantity in mg, of the reference substance in the 20-ml aliquot of the 
standard solution.  
 
The quantity of the steroid in the substance being examined was calculated on 
the basis of the aliquot the test solution taken for the determination and from the 
declared content of the steroid in the appropriate reference substance. 
 
FLUORESCENCE ANALYSIS56, 57 
Many crude drug show Fluorescence when the sample is exposed to UV 
radiation. Evaluation of crude drugs based on fluorescence in day light is not much 
used, as it is usually unreliable due to the weakness of the fluorescent effect. 
Fluorescent lamps are fitted with suitable filter, which eliminate visible radiation from 
the lamp and transmits UV radiation of definite wavelength was used for the study 
several crude drugs show characteristic fluorescence which is very much useful for 
their evaluation. 
 
CHROMATOGRAPHY 
Chromatographic methods are important analytical tool for the separation and 
identification of active components present in the plant. 
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THIN LAYER CHROMATOGRAPHY58 
Principle 
The principle of separation is adsorption. It is reliable technique in which 
solute undergoes distribution between two phases, stationary and mobile phase. The 
mobile phase flows through because of capillary action (against gravitational force). 
The compounds having higher affinities towards the stationary phase eluted slower 
were as the compound having lesser affinities towards stationary phase eluted faster. 
 
TLC Plate Preparation 
The plates were prepared using Stahl TLC spreader. 40gm of silica gel G was 
mixed with 85ml of water to prepare homogenous suspension and poured in the 
spreader. 0.25mm thickness of plates was prepared, air dried until the transparency of 
the layer disappeared, then dried at 110ºC for 30 minutes and kept in desiccators. 
 
Selection of mobile phase 
Solvent mixture was selected on the basis of the phytoconstituents present in 
each extract. Factors such as nature of components, stationary phase, polarity, 
influence the rate of separation of constituents was considered. From the vast analysis, 
best solvents were selected which showed good separation with maximum number of 
components. 
 
HPTLC- FINGERPRINT PROFILE59 
HPTLC is one of the versatile chromatographic method which helps in the 
identification of compounds and thereby authentication of purity of herbal drugs. The 
time required in this method for the demonstration of most of the characteristic 
constituents of a drug is very quick and short. In addition to qualitative detection, 
HPTLC also provides semi- quantitative information on major active constituents of a 
drug, thus enabling an assessment of drug quality. 
 
Rf  values 
 Distance travelled by solute from the baseline 
= 
_____________________________________ 
 
 Distance travelled by solvent from the  baseline 
 Phytochemical Studies 
 
Department of Pharmacognosy , MMC. Page 42 
 
HPTLC serves as a convenient tool for finding the distribution pattern of 
phytoconstituents which is unique to each plant. The fingerprint obtained was suitable 
for monitoring the identity and purity of drugs and for the detection of adulteration 
and substitution. HPTLC technique is helpful in order to check the identity, purity and 
to standardize the quantity of active principles in the herbal extract. 
 
Instrument Conditions: 
Sample used  :  Ethanol Extract of bark of Sterculia foetida Linn., 
Instrument  : CAMAG HPTLC 
Stationary phase :  Aluminum coated silica Gel-Merk F254 
Volume of injection : 20µl 
Mobile phase  :  Ethyl acetate : Toluene : Methanol : Formic acid  
    (6:2:1:1) 
Derivatizing agent : 10% Anisaldehyde in sulphuric acid 
Lamp   : Tungsten 
Lambda max  : 400-800nm 
 
The estimation has been done using the following chromatographic conditions. 
Chromatography was performed on a 12 × 3 cm (H x W) pre-activated HPTLC silica 
Gel Merk F254 plate. Samples were applied to the plate as 6mm wide band with an 
automatic TLC applicator 8mm from the bottom. 
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7.2. RESULTS AND DISCUSSION 
Phytochemical investigations were carried and the results are as follows. 
 
Table no: 6 Percentage yield of successive extracts of bark of  
Sterculia foetida Linn., 
S.NO EXTRACT METHOD OF EXTRACTION 
PHYSICAL 
NATURE COLOUR 
YIELD 
(%W/W) 
 
1. n-Hexane 
Continuous 
percolation 
method using 
Soxhlet apparatus 
Solid Buff colour 1.64 
2. Chloroform Semisolid Brown 
colour 1.28 
3. Ethyl 
acetate Semisolid 
Brown 
colour 1.08 
4. Ethanol Solid Brown 
colour 2.26 
 
QUALITATIVE PHYTOCHEMICAL ANALYSIS 
TABLE NO: 7 PRELIMINARY PHYTOCHEMICAL ANALYSIS 
S.NO CHEMICAL CONSTITUENTS 
POWDERED 
DRUG 
n-HEXANE 
EXTRACT 
CHLOROFORM 
EXTRACT 
ETHYL 
ACETATE 
EXTRACT 
ETHANOL 
EXTRACT 
1. Steroids + + + + + 
2. Glycosides - - - - - 
3. Saponins - - - - - 
4. Flavonoids + - + + + 
5. Tannins + - - + + 
6. Triterpenes + + + + + 
7. Proteins + - - - + 
8. 
 
Alkaloids + - + + + 
9 
 
Carbohydrates + - + + + 
10. Fats and oils - - - - - 
 
Note:    +  - Indicates the presence and absence  
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 From the qualitative analysis, it was observed that the ethanol extract showed 
the presence of maximum active constituents such as flavonoids, tannins, triterpenes, 
proteins and alkaloids. All these compounds were found in the powdered bark also. 
The ethyl acetate extract also showed the presence of more number of active 
constituents. Chloroform extract showed the presence of flavonoids, teriterpenes and 
alkaloids. n-Hexane extract showed the presence of steroids and teriterpenes. 
 
QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
 The phytoconstituents like alkaloids, steroids, phenolic compounds and 
flavonoids were   estimated quantitatively by HPLC method. The results were shown 
in the table no: 8. 
TABLE NO: 8 QUANTITATIVE ESTIMATION OF ALL THE 
EXTRACTS 
S.No Parameters n-Hexane (mg/ml) 
Chloroform 
(mg/ml) 
Ethyl 
acetate 
(mg/ml) 
Ethanol 
(mg/ml) 
1. Total Alkaloids - 3.56 5.11 6.33 
2. Total steroids 6.09 2.09 3.02 4.11 
 
3. 
 
 Flavonoids   
Quercetin 1.03 0.09 0.08 0.09 
Rutin - 0.81 0.813 0.413 
Kamferol - 0.095 - 0.396 
Thymoquine - 0.645 0.041 0.263 
 Gallagin - 0.034 - 0.044 
4. 
            Phenolic compounds 
Ascorbic acid 0.92 0.53 0.65 1.34 
Tannic acid - 1.45 0.98 0.98 
Gallic acid - 0.545 0.74 2.45 
Coumaric acid - 0.84 0.094 1.35 
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FIG NO: 24 ESTIMATION OF FLAVONOID CONTENT BY HPLC 
METHOD 
 
  
n-HEXANE EXTRACT OF  
Stercuia foetida Linn., 
CHLOROFORM EXTRACT OF 
Stercuia foetida Linn., 
  
ETHYL ACETATE EXTRACT OF 
Sterculia foetida Linn., 
ETHANOL EXTRACTOF  
Sterculia foetida Linn., 
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FIG NO: 25 ESTIMATION OF PHENOLIC CONTENT BY HPLC METHOD 
  
n-HEXANE EXTRACT OF  
Sterculia foetida Linn., 
CHLOROFORM EXTRACT OF 
Sterculia  foetida Linn., 
  
ETHYL ACETATE EXTRACTOF 
Sterculia foetida Linn., 
ETHANOL EXTRACT OF  
Sterculia foetida Linn., 
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FLUORESCENCE ANALYSIS 
TABLE NO: 9 FLUORESCENCE CHARACTERISTIC OF POWDERED 
BARK OF Sterculia foetida Linn., 
S.NO TREATMENT DAY LIGHT 
SHORT UV 
(254nm) 
 
LONG UV 
(366nm) 
 
1. Powder Orange brown Blackish Brown Orange 
2. Powder + water Orange  brown Blackish Brown Orange 
3. Powder + NaoH Brown Dark brown Reddish brown 
4. Powder + HCl Pale 
orange Black Light orange 
5. Powder + Acetic acid Yellow Black Orange 
6. Powder + Alc.NaoH Brown Dark brown Reddish brown 
7. Powder + Picric acid Yellow Brown orange 
8. Powder + Sulphuric 
acid Black Black Black 
9. Powder + Nitric acid Reddish brown Black Red 
10. Powder + Iodine Brown Dark  brown Orangish brown 
11. Powder + Fecl3 Green Dark green Light green 
12. Powder + KOH Brown Black Reddish orange 
13. Powder + alc.KOH Brown Black Reddish orange 
14. Powder + ammonia Light brown Black Orange 
15. Powder + ethanol Light brown Dark brown Orange 
 
 
 
 Phytochemical Studies 
 
Department of Pharmacognosy , MMC. Page 48 
 
 
TABLE NO: 10 FLUORESCENCE ANALYSIS OF VARIOUS BARK 
EXTRACTS OF Sterculia foetida Linn.,  
S.NO TREATMENT DAY LIGHT 
 
SHORT UV 
(254nm) 
 
LONG UV 
(366nm) 
1. n-Hexane Buff colour Pale brown Buff colour 
2. Chloroform Dark red Black Brown 
3. Ethyl acetate Dark red Black Brown 
4. Ethanol Dark red Black Brown 
 
There was no characteristic fluorescence were seen with either the powdered 
bark or the extracts. 
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CHROMATOGRAPHIC STUDIES 
 
THIN LAYER CHROMATOGRAPHY  
Thin layer chromatography was done with all the four extracts and their Rf 
values were tabulated in the table no: 11. 
 
TABLE NO: 11 THIN LAYER CHROMATOGRAPHIC STUDIES OF 
EXTRACT 
 
S.NO 
 
EXTRACTS 
 
SOLVENT SYSTEM 
 
NO. OF 
SPOTS 
 
RF VALUES 
 
1. 
 
n-Hexane 
 
Toluene : methanol 
(9:1) 
 
1 
 
0.7 
 
2. 
 
Chloroform 
 
Toluene : methanol 
(9:1) 
 
2 
 
0.28, 0.56 
 
3. 
 
Ethyl acetate 
 
Ethyl acetate : 
acetonitrile (3:2) 
 
2 
 
0.31,0.45 
 
4. 
 
Ethanol 
Ethyl acetate : Toluene 
: Methanol : Formic 
acid (6:2:1:1) 
 
4 
 
0.33,0.45.0.57,0.71 
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HPTLC FINGER PRINT PROFILE 
 
HPTLC Finger print Data of Ethanolic Extract of Sterculia foetida Linn., 
Since the yield of ethanolic extract was high and it was found to contain more 
phytoconstituents it was selected for the HPTLC studies. High performance thin layer 
chromatography (HPTLC) finger printing was performed with the ethanol extract of 
Sterculia foetida Linn., 
FIG NO: 26 HPTLC OF ETHANOLIC EXTRACT 
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FIG NO: 27 HPTLC FINGER PRINT OF ETHANOLIC  
EXTRACT OF Sterculia foetida Linn., 
 
 
 
FIG NO: 28 HISTOGRAM OF ETHANOLIC EXTRACT OF  
BARK OF Sterculia foetida Linn., 
 
 
  
 Phytochemical Studies 
 
Department of Pharmacognosy , MMC. Page 52 
 
FINGER PRINT DATA ANALYSIS FOR HPTLC 
 
TABLE NO: 12 HPTLC FINGER PRINT DATA 
S. No Rf Height Area Lambda Max 
1 0.10 6.3 44.1 800 
2 0.11 3.3 62.3 710 
3 0.17 5.8 86.6 710 
4 0.22 4.0 80.6 710 
5 0.25 3.8 100.6 710 
6 0.33 4.6 81.9 710 
7 0.34 6.1 191.9 710 
8 0.45 1.5 24.7 710 
9 0.49 10.3 206.6 710 
10 0.54 8.6 236.2 710 
11 0.64 41.9 1949.5 610 
12 0.69 18.1 753.2 710 
 
There were 12 peaks was observed with different Rf values and different 
percentage of areas. HPTLC was scanned at 460nm with the best solvent to detect the 
maximum number of components and peak abundance quantitatively. The finger print 
of ethanolic extract showed 12 peaks with different Rf values. 
Since secondary metabolites are responsible for biological activity, this study 
would be the leading pathway of information for selection of extract for 
pharmacological activity and isolation of constituents responsible for the activity. 
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9. SELECTION OF ACTIVE EXTRACT 
 
9.1. MATERIALS AND METHODS 
The plant Sterculia foetida Linn., contains many active constituents in each 
extracts. Hence for all the extracts in order to select the best extract in-vitro studies 
were carried out. 
 
 Hence all the extracts of bark of Sterculia foetida were subjected to in-vitro 
antioxidant activity and anti-arthritic activity studies. These studies are used for the 
selection of best active extract which would take to precede the further activities. 
 
IN VITRO ANTIOXIDANT ACTIVITY60 
 Antioxidant is a molecule that inhibits oxidation of other molecule which 
produces free radicals. These radicals in turns produce chain reactions there by cause 
damage to the cells, resulting in development of various ailments. Antioxidants 
terminate these chain reactions by removing free radicals and inhibiting oxidative 
reactions. Therefore, antioxidant with free radical scavenging effect will be of greater 
importance in the prevention and therapeutics of disease.  
 
DPPH ASSAY (2, 2-DIPHENYL -1-PICRYLHYDRAZYL) 
 Antioxidants react with DPPH and reduce it to DPPH-H and as consequence 
the absorbance decreases. The degree of discolouration indicates the scavenging 
potential of the antioxidant compounds or extracts in terms of hydrogen donating 
ability.  Different volumes (1.25-10µl) of plant extracts were made up to 40µl with 
DMSO and 2.96ml DPPH (0.1mM) solution was added. The reaction mixture was 
incubated in dark condition at room temperature for 20 minutes. After 20 minutes, the 
absorbance of the mixture was read at 517nm. 3ml of DPPH was taken as control. 
 
 
 
 
 
                        Abs(control) - Abs(test)  
% Inhibition = ____________________________ X 100 
 
                      Abs(control)  
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NITRIC OXIDE SCAVENGING ACTIVITY 
Nitric oxide scavenging activity of the extract was determined by using 
aqueous solution of sodium nitroprusside which generates nitric oxide (NO) 
spontaneously at physiological pH. NO interacts with oxygen to produce nitrate ions 
which were measured calorimetrically. 3 ml of reaction mixture containing 2 ml of 
sodium nitroprusside (10mM) in Phosphate buffer solution and 1 ml of various 
concentrations of successive extracts were incubated at 37°C for 4 hours. Control 
without test compound was kept in the same manner. After incubation 0.5 ml of 
Griess reagent (0.2% naphthylenediaminedihydrochloride, 2% sulphanilamide in 5% 
phosphoric acid) was added. The absorbance of the chromophore formed was read at 
546 nm and compared with standard Ascorbic acid. 
 
IN-VITROANTI-ARTHRITIC ACTIVITY61 
PROTEIN DENATURATION METHOD 
The test and standard solutions were prepared and pH was adjusted to 6.3 to 
all the solution by using 1N HCl. All the sample solution was incubated at 37OC for 
20minutes and the temperature was increased to 57OC for 3 minutes. Allowed to cool 
for some time then 2.5ml of Phosphate buffer was added to all the above solutions. 
The absorbance was measured at 416nm using UV visible spectrophotometer. The 
Percentage inhibition of protein denaturation was calculated.   
 
 
 
 
% Inhibition     
= 
 
Abs(control) - Abs(test)  
__________________________________ X 100 
 
Abs(control) 
 
Protein 
denaturation 
assay 
= 
    (O.D Test compound - O.D control) 
 
__________________________________ X 100 
 
  (O.D control) 
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RESULTS 
 
IN-VITRO ANTIOXIDANT ACTIVITY 
DPPH ASSAY (2, 2-DIPHENYL -1-PICRYLHYDRAZYL) 
 
TABLE NO: 13 PERCENTAGE INHIBITION OF EXTRACTS-DPPH ASSAY 
Extract 
% Inhibition at various concentrations 
10 
µg/ml 
20 
µg/ml 
40 
µg/ml 
80 
µg/ml 
100 
µg/ml 
Ascorbic acid 61.03 68.88 75.04 82.04 88.31 
n-Hexane 34.75 41.28 47.96 53.91 58.76 
Chloroform 35.20 46.07 53.24 59.77 62.08 
Ethyl acetate 39.48 49.09 56.52 61.84 67.31 
Ethanol 56.09 62.15 68.23 73.01 79.53 
 
FIG NO: 29 GRAPHICAL DATA OF PERCENTAGE INHIBITION 
 
 
 
 In DPPH assay the scavenging potential of the antioxidant compounds or 
extracts were found. The percentage inhibition of n-Hexane, Chloroform, Ethyl 
acetate and Ethanol was found to be 58.76, 62.08, 67.31 and 79.53 respectively at a 
maximum concentration of 100µg/ml. The percentage inhibition of Ascorbic acid 
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(Standard) was found to be 88.31. In that ethanolic extract showed the maximum 
percentage of inhibition which is comparable to the standard.   
 
NITRIC OXIDE SCAVENGING ASSAY 
 
TABLE NO: 14 PERCENTAGE INHIBITION OF EXTRACTS- 
NITRIC OXIDE SCAVENGING ASSAY 
Extract 
% Inhibition at various concentrations 
 
10 
µg/ml 
20 
µg/ml 
40 
µg/ml 
80 
µg/ml 
10 
µg/ml 
Ascorbic acid 64.85 69.08 76.10 82.99 89.01 
n-Hexane 33.41 38.81 44.22 51.27 56.62 
Chloroform 38.06 46.35 56.16 62.08 67.41 
Ethyl acetate 43.06 54.63 60.54 69.40 74.58 
Ethanol 55.04 69.14 69.29 76.29 81.19 
 
FIG NO: 30 GRAPHICAL DATA OF PERCENTAGE INHIBITION 
 
 
In nitric oxide scavenging assay the scavenging potential of all the extracts 
were found. The percentage inhibition of all the extracts was found to be 56.62, 67.41, 
74.58 and 81.19 respectively at the maximum concentration of 100µg/ml. The 
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percentage inhibition of Ascorbic acid (Standard) was found to be 89.01. This result 
showed that ethanolic extract showed the maximum percentage inhibition and possess 
maximum scavenging activity which is compared with the standard.   
 
INVITRO ARTHRITIC ACTIVITY 
PROTEIN DENATURATION METHOD 
TABLE NO: 15 PERCENTAGE INHIBITION OF EXTRACTS –  
PROTEIN DENATURATION METHOD 
Extract 
% Inhibition at various concentrations 
10 
µg/ml 
20 
µg/ml 
40 
µg/ml 
80 
µg/ml 
10 
µg/ml 
Diclofenac sodium 40.85 56.63 63.20 79.31 86.41 
n-Hexane 28.70 35.23 41.12 53.69 58.71 
Chloroform 30.86 38.30 49.07 57.62 63.54 
Ethyl acetate 32.12 40.13 54.18 66.58 72.30 
Ethanol 36.27 42.36 57.96 69.03 78.09 
 
FIG NO: 31 GRAPHICAL DATA OF PERCENTAGE INHIBITION 
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The percentage inhibition of protein denaturation assay by n-Hexane, 
Chloroform, Ethyl acetate and Ethanol was found to be 58.71, 63.54, 72.30 and 78.09 
respectively at maximum concentration of 100µg/ml. Percentage inhibition of 
Diclofenac sodium (Standard) was found to be 86.41. The results indicated that 
ethanolic extract showed the maximum percentage inhibition which is compared with 
the standard. 
 
Both the antioxidant studies and inhibition of protein denaturation assay 
indicated that of all the extracts, the ethanolic extract showed the maximum 
scavenging and inhibitory activity. This correlates with the findings of the 
phytochemical study where the ethanol extract showed the presence of most of the 
phytoconstituents. 
 
Further studies are focused on invivo ant-arthritic activity of ethanolic extract 
and isolation of phytoconstituents which is responsible for the activity. 
 
 
 
  
 
 
Pharmacological studies 
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10. PHARMACOLOGICAL STUDIES 
10.1. ACUTE TOXICITY STUDY 
10.1.1. MATERIALS AND METHOD 
ACUTE TOXICITY STUDY (OECD 423 GUIDELINES)62 
PROCEDURE: (Acute toxicity study is designed as per the OECD guidelines 
423). 
Adult Wistar albino rats of either sex weighing between 150-200g of 3 
animals were selected for study. All the animals were fasted overnight provided with 
water ad libitum. Following period of fasting the test compound was administered at a 
dose of 2000mg/kg body weight orally. 
Animals were observed individually after dosing periodically during the first 
30 minutes to the first 24 hours, with special attention given during the first 4 hours 
and daily thereafter, for a total of 14 days. Observation includes changes in skin and 
fur, eyes and mucous membranes and also respiratory, circulatory, automatic, central 
nervous system, somato motor activated and behavioral pattern. Attention should be 
directed to observation of tremors, convulsions, salivation, diarrhea, lethargy, sleep 
and coma. 
The rats were observed regularly for 14 days to note the mortality or toxic 
symptoms. If no deaths were reported, the study was repeated with same dose to 
confirm the results. 
FIG NO: 32 OECD Guidelines 423 
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10.1.2. RESULTS AND DISCUSSION 
 
TABLE NO: 16 ACUTE TOXICITY-PARAMETERS STUDIED 
 
OBSERVATION 30 mins 4 hrs 24 hrs 14th day 
Body weight - - - - 
Pre terminal deaths - - - - 
Cage side 
observation + + + + 
Motor activity + + + + 
Convulsions - - - - 
Pilorection - - - - 
Righting reflex + + + + 
Lacrimation - - - - 
Salivation - - - - 
Respiration + + + + 
Skin color + + + + 
Diarrhea - - - - 
Loss of corneal 
reflex - - - - 
Loss of pinnal reflex - - - - 
Grooming - - - - 
Sedation - - - - 
Excitation + + + + 
Aggression + + + + 
NOTE: +, - Indicates presence or absence 
 
 Since there were no death and behavioral changes observed. The extract was 
considered as safe to administer. From this 1/10th and 1/5th of the dose (200mg and 
400mg) were selected for further studies. 
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10.2. ANTI-ARTHRITIC ACTIVITY63-69 
10.2.1. MATERIALS AND METHOD 
 
ADJUVANT INDUCED ARTHRITIS MODEL 
This is one of the most commonly used animal models for evaluating anti-
arthritic activity. Arthritis is induced in rats by intra plantar injection of 0.1ml of 
Complete Freund's Adjuvant (CFA) in left hind paw except for the vehicle control. 
The adjuvant contained heat killed mycobacterium tuberculosisin sterile paraffin oil. 
The test drug and the standard drug will be administered orally for a period of 21 days 
and the paw volume was measured periodically using plethysmograph. 
 
Test drug - Ethanolic extract were given at the dose of 1/10th (200mg/kg) and 
1/5th (400mg/kg) for 21 days. 
 
EXPERIMENTAL ANALYSIS  
A total of 30 adult Wistar albino rats weighing (150-200g) were divided into 5 
groups of 6 animals in each group. 
 
TABLE NO: 17 GROUPING OF ANIMALS 
S.NO GROUP NAME OF THE GROUP TREATMENT 
1 I Positive control Treatment with vehicle for 21 days 
2 II Arthritic control Treated with CFA 
3 III CFA + Standard Treatment with Diclofenac sodium 15mg/kg for 21 days 
4 IV CFA + Test drug1 Treatment with ethanol extract 200mg/kg for 21 days 
5 V CFA + Test drug2 Treatment with ethanol extract 400mg/kg 21 days 
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PARAMETERS STUDIED 
CHANGES IN BODY WEIGHT 
 Body weight changes were observed every week. 
 
PAW VOLUME MEASUREMENT 
 Paw volume of all the animal groups were measured by using plethysmograph 
at 0, 7, 14 and 21 days. The percentage inhibition of paw volume can be determined 
using this formula. 
 
( Vc - V0 ) - ( Vt - V0 ) X 100 
=       ------------------------------------- 
( Vc - V0 ) 
where,             Vc - is the paw volume after induction  
            V0 - is the paw volume before induction 
                       Vt - is the paw volume after treatment.  
 
SECONDARY LESIONS 
Secondary lesions developed in ears, fore limbs, hind limbs and tails were 
scored. 
 
HEMATOLOGICAL PARAMETERS 
At the end of the experimental period (22nd day) the blood was collected from 
the animal through retro- orbital vein puncture of all the groups and the hematological 
parameters such as hemoglobin content, RBC count, WBC count, Hemoglobin and 
ESR were studied. 
 
RADIOGRAPHICAL STUDIES 
At the end of the experimental period, X- ray were taken for the hind limbs of 
experimental animals and examined for soft tissue swelling, bony erosions and 
narrowing of the spaces between the joints. 
 
HISTOPATHOLOGICAL STUDIES 
At the end of the experiment, animals were sacrificed by cervical decapitation 
for the evaluation of histopathological changes like soft tissue swelling, bone 
demineralization, pannus formation, cartilage erosion and joint space narrowing. 
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10.2.2. RESULTS AND DISCUSSION 
 
IN-VIVO EVALUATION OFANTI-ARTHRITIC ACTIVITY BY 
ADJUVENT INDUCED ARTHRITIS (Complete Freund’s Adjuvant) 
 
TABLE NO: 18 CHANGES IN THE BODY WEIGHT IN (GM) 
ADJUVANT-INDUCED ARTHRITIC RATS 
 
Treatment 0th day 7th day 14th day 21st day 
Group I 154 ±4.74 161 ± 9.58** 163 ± 9.3380** 167 ±10.30** 
Group II 
(Arthritic 
control) 
162 ± 6.408 159± 6.91* 157± 56.64* 154 ± 5.780* 
Group III 
Diclofenac 
sodium 
153 ± 8.846 157 ± 2.87*** 161 ± 2.13*** 164 ± 2.31b*** 
Group IV 
200 mg/ kg  156 ± 4.49 158 ±5.09*** 160 ±6.33*** 163 ± 4.81*** 
Group V 
400mg / kg  163 ± 5.79b 164 ±2.81*** 168 ±4.979*** 171 ± 5.42*** 
 
Values represented in the result are mean ± SD (n=6) 
*p< 0.05, **p < 0.01, ***p < 0.001 as compared to the positive and arthritis control. The 
data was analyzed using one way analysis of variance (ANOVA) followed by Tukey 
HSD Test.  
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FIG NO: 33 GRAPHICAL DATA OF CHANGES IN BODY WEIGHT- 
ADJUVANT INDUCED ARTHRITIC RATS 
 
 
 
The body weight of the different groups of rats was noted. During the 
treatment the body weight of the control, standard, test dose I and test dose II animals 
were increased except arthritis induced rats. 
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HAEMATOLOGICAL PARAMETERS  
 
TABLE NO: 19 EFFECT OF HEMATOLOGICALPARAMETERS - 
ADJUVANT INDUCED ARTHRITIC RATS 
PARAMETERS 
RBC count 
(pre 
cu.mm) 
WBC count 
(pre cu.mm) 
Hb 
(g/dL) 
ESR 
(mm/h.) 
Group I 
( Control ) 8.01±0.138 12.03± 1.15** 14.9±0.346** 3.56±0.342** 
Group II 
(Arthritic 
control) 
4.68±0.147 7.84±1.16* 9.3±0.257* 11.9±0.694* 
Group III 
(Diclofenac 
sodium) 
8.04± 0.264 12.0±0.41*** 13.16±0.151*** 7.9± 1.48*** 
Group IV 
(200 mg/ kg) 6.50±0.235 5.4±8.216*** 11.0±0.258*** 8.06±1.27*** 
Group V 
(400mg/kg) 6.69±0.102 9.4±0.755*** 12.5±0.207*** 7.5±0.843*** 
 
*p< 0.05, **p < 0.01, ***p < 0.001 as compared to the positive and arthritis control. 
The data was analyzed using one way analysis of variance (ANOVA) followed by 
Tukey HSD Test. 
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FIG NO: 34 GRAPHICAL DATA FOR EFFECT OF HEAMOTOLOGICAL 
PARAMETERS- ADJUVANT INDUCED ARTHRITIC RATS 
 
 
 
          The results indicate that arthritic group of animals showed decreased RBC, 
WBC and Hemoglobin levels. But the ESR level showed the increased value which is 
compared with the control group. In the standard group all the blood parameters are 
brought back to the normal levels. In the group which is treated with 200mg/kg 
showed the improvement of blood parameters and the extract of 400mg/kg showed 
significant improvement in blood parameters than the 200mg/kg treated animals. 
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PAW VOLUME MEASUREMENT 
TABLE NO: 20 MEASUREMENT OF PAW VOLUME USING 
PLETHYSMOGRAPH- ADJUVANT-INDUCED ARTHRITIC RATS 
 
Treatment 0 day 7th day 14th day 21st day 
Group I 
(Control) 2.46±0.54 2.63 ±0.45** 2.94 ±.14** 2.98±0.32** 
Group II 
(Arthritic 
control) 
2.68 ± 0.21 15.22 ± 0.15* 16.79 ± 0.32* 18.32± .142* 
Group III 
Diclofenac 
sodium 
2.41±0.34 10.27±0.17*** 8.23±0.14*** 5.96 ± 0.13*** 
Group IV 
(200 mg/ kg) 2.62±0.113 12.56±0.213*** 
11.69 ± 
0.16*** 9.54±0.019*** 
Group V 
(400mg/kg) 2.73±0.21 12.32± 0.14*** 
9.98 ± 
0.145*** 6.89±0.018*** 
 
*p< 0.05, **p < 0.01, ***p < 0.001 as compared to the positive and arthritis control. 
The data was analyzed using one way analysis of variance (ANOVA) followed by 
Tukey HSD Test. 
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FIG NO: 35 PAW VOLUME MEASUREMENT- ADJUVANT INDUCED 
ARTHRITIC RATS 
 
 
 
*p< 0.05, **p < 0.01, ***p < 0.001 as compared to the positive and arthritis control. 
The data was analyzed using one way analysis of variance (ANOVA) followed by 
Tukey HSD Test. 
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TABLE NO: 21 PERCENTAGE INHIBITION OF PAW VALUE - ADJUVANT 
INDUCED ARTHRITICRATS 
 
Treatment 7th day 14th day 21st day 
Group I  
(Positive control) 0 0 0 
Group II  
(negative control) 0 0 0 
Group III 
(Diclofenac sodium) 
32.52 50.98 67.46 
Group IV 
(200 mg/ kg) 
17.47 30.37 47.92 
Group V 
(400mg/kg) 
19.05 40.55 62.39 
 
            The Percentage inhibition of paw volume of all the group of was found. The 
standard group, test dose 200mg/kg and test dose 400mg/kg were studied for the 
different intervals of time. The standard group showed maximum percentage 
inhibition and the test dose 400mg/kg showed better percentage inhibition than test 
dose 200mg/kg. It indicates that 400mg/kg test dose showed significant arthritic effect 
on rats.  
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RADIOGRAPHY STUDY 
 
The proximal inter phalangeal joints were removed and washed with saline and stored 
in 10% formalin. These joints were subjected to radio graphical studies. 
 
          The radiographic images of hind limb of rats were taken and discussed as 
follows. 
 
• Group I :   Normal control group showed no changes in the joints. 
• Group II : Arthritic control group showed destruction of bones at joints, 
narrowing of joints and swelling of soft tissues are seen. 
• Group III :  Standard group (Diclofenac sodium) showed no destruction of 
bones at joint, swelling of soft tissues are reduced to normal. 
• Group IV :  Test dose I (200mg/kg) showed mild destruction of bones and 
swelling of soft tissues. 
• Group V : Test dose II (400mg/kg) showed the mild changes in the joint and 
complete reduced swelling of soft tissues. 
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RADIOGRAPHY OF BONE 
 
 
 
FIG NO: 36 POSITIVE CONTROL FIG NO: 37 NEGATIVE CONTROL 
 
 
FIG NO: 38 STANDARD 
(DICLOFENAC SODIUM) 
FIG NO: 39 TEST DOSE 200mg/kg 
 
FIG NO: 40 TEST DOSE 400mg/kg 
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HISTOPATHAOLOGICAL EXAMINATION OF BONE 
 
• Group I :   Normal control group showed normal cartilage. 
• Group II : Arthritic control group showed erosion of bone and formation of 
edema. 
• Group III :  Standard group (Diclofenac sodium) showed normal cartilage and 
no formation of edema occurs. 
• Group IV :  Test dose I (200mg/kg) showed mild erosion of bones. 
• Group V : Test dose II (400mg/kg) showed normal cartilage and absence of 
edema. 
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HISTOPATHOLOGY OF BONE 
 
 
FIG NO: 41 POSITIVE CONTROL FIG NO: 42 ARTHITIC CONTROL 
 
 
FIG NO: 43 STANDARD 
(DICLOFENAC SODIUM) 
FIG NO: 44 TEST DOSE 200mg/kg 
 
FIG NO: 45 TST DOSE 400mg/kg 
 
  
 
 
Isolation and Identification 
of Lupeol 
 Isolation and Identification of Lupeol 
 
Department of Pharmacognosy , MMC. Page 74 
 
 
11. ISOLATION AND IDENTIFICATION OF LUPEOL 
 
             Since lupeol was found to possess anti-inflammatory and anti-arthritic 
activity75 an attempt was made to isolate and identify the lupeol from the Ethanol 
extract of Sterculia foetida Linn., Lupeol is a pentacyclic triterpenoid derivative. 
Chemically it is hexamethyl-1-prop-1en-2yl-hexadecahydrocyclopenta-chrysen-9-ol. 
The molecular formula of lupeol is C30H50O and the molecular weight is 426.73g.mol. 
It has several medicinal properties. 
 
Occurrence 
Lupeol is found in a variety of plants, including mango, Acacia visco, and Abronia 
villosa. It is also found in dandelion coffee. 
 
Chemical properties 
 
FIG N0: 46 STRUCTURE OF LUPEOL 
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11.1. Materials and method 
Extract used    :    Ethanol extract 
Method            :    Column chromatography 
 
Procedure   
              The separation of compounds was achieved by column chromatograghy73. 
Then weighed quantity of ethanolic extract was subjected in to the column 
chromatography on a silica gel, the column is packed using 100% n-Hexane. The 
solvent system used for the elution is Ethanol : Ethyl acetate (50:50). Eluents were 
collected in 25ml aliquots, evaporated to dryness and was further subjected to 
purification. This compound appeared as white needles and was subjected to spectral 
analysis. 
 
Spectral studies 
              The isolated compound was subjected to IR, NMR and GC-MS analysis. 
 
Infra-red spectroscopy 
It is the absorption spectrum of different IR frequencies by a sample positioned in the 
path of an IR beam. It is carried out for the determination of functional groups in the 
sample. The commonly used method is pressed pellet technique for solid sample and 
Nujol mull technique for liquid sample. With this technique the isolated sample is 
investigated for the functional groups.  
 
NMR SPECTROSCOPY 
            It is technique in which position of the Hydrogen and Carbon atoms were 
identified. NMR spectra were acquired on a Varian Unity Pulse 600 MHZ instrument 
using standard pulse sequences at ambient temperature. Chemical shifts are given in δ 
(ppm) and coupling constants are reported in HZ. The samples were diluted with water 
: acetonitrile : methanol (1:2:2) and stock solution were prepared. The sample was 
introduced using syringe pump at a flow injection rate of 120µl/min. sample was 
studied for both H1 NMR and C13 NMR respectively. 
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GC-MS ANALYSIS 
            The extract was subjected to GC-MS analysis. Chromatographic separation 
was carried out for the isolated compound. Helium used as a carrier gas with a flow 
rate of 1 ml/min in the split mode. An aliquot amount of sample was injected into the 
column with the injector, heater at 250ºC. The data analysis of compound was noted 
in mass spectra in which the detector operated in scan mode from 20 to 600 atomic 
mass units (amu). Identifications were based on the molecular structure, molecular 
mass and calculated fragmentations. 
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11.2. RESULTS AND DISCUSSION 
 
PHYSICAL AND CHEMICAL PROPERTIES OF ISOLATED COMPOUND 
 
Colour Greenish white 
Nature Solid (needle shaped crystals) 
Melting point 215º C 
Solubility Soluble in water, chloroform, ethanol and methanol 
Chemical test Libermann Burchards Test  
 Formation of brown indicates presence of triterpenoids. 
TLC Solvent system Ethyl acetate : Toluene : Methanol : Formic acid (6:2:1:1) 
Rf value 0.68 
 
IR SPECTROSCOPY 
 
TABLE NO: 22 IR SPECTRUM DATA FOR ISOLATED COMPOUND 
S.no. Observation Observed wave 
number (cm-1) 
Standard wave76 
number (cm-1) 
1. O-H Stretching 3315.78 3434.61 
2. C-H Stretching alkane 2934.82 2947.33 
3. C=C Stretching alkene 1642.46 1640.99 
4. C-H stretching alkyl 1459.21 1463.14 
4. C-H alkene 2867.31 2873.33 
5. CH3 Stretching 1376.27 1382.55 
6. C-C Stretching 1057.04 1062.72 
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FIG NO: 47 IR SPECTRUM FOR ISOLATED COMPOUND 
 
 
            The isolated compound was subjected to IR studies and the results were 
compared with the standard lupeol for reference. 
 
NMR SPECTROSCOPY 
Molecular formula  C30H50O  
M+ peak  424 [M+];  
1H NMR  
 7.21 (m - 1H, H-6), 7.19 (s- 1H), 4.16 (s - 1H), 4.14 (s - 1H), 3.62 (tdd - OH, 
H-3), 1.27 (s – 3H), 1.19 (s- 3H), 1.07 (s – 3H), 0.99 (s – 3H). 
 
13C NMR 
212.8 (C- 3), 150.4 (C-20), 108.8 (C-29), 59.3 (C-5), 58.0 (C-9), 53.1 (C-18), 
42.6 (C-19), 42.2 (C-17), 41.6 (C-4), 41.4 (C-14, 8), 40.4 (C-22), 39.7 (C-1), 36.0 (C-
10, 16), 35.6 (C-13), 35.1 (C-2), 33.1(C-7), 32.3 (C-23), 32.0 (C-24), 30.2 (C-15), 
29.7 (C-21), 29.4 (C-12), 22.5 (C-11), 21.0 (C-30), 20.2 (C-28), 18.9(C-25), 18.5 (C-
6), 18.0 (C-26), 15.1 (C-27). 
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The mass spectral data of compound gave a molecular ion peak at m/z 424 
corresponding to its (M)+ ion suggesting the molecular formula as C30H50O. 
 
The 1H NMR spectra of compound showed the presence of seven methyl 
singlets at 7.12, 7.19, 4.16, 1.27, 1.19, 1.07 and 0.99.The 1H NMR spectra of 
compound also showed the presence of two protons appeared at 3.62 and 4.14 as 
singlets representing the exocyclic double bond protons. The 13C NMR spectrum of 
compound showed a saturated carbonyl group at 212.8 and the alkene carbons at 
150.4 and 108.8 suggesting the presence of a lupane triterpene having a carbonyl 
group in its structure. The 1H and 13C NMR values for all the protons and carbons 
were assigned on the basis of COSY, HMQC and HMBC correlations as reported 15-
17 and were given in materials and methods. Considering lupane skeleton for the 
compound together with the absence of a hydroxyl group and the appearance of a 
carbonyl group in the 13C NMR spectral data suggested the presence of a keto 
functional group and its presence was identified at C-3 position by the key HMBC 
correlations. 
 
FIG NO: 48 H1 NMR SPECTRUM FOR ISOLATED COMPOUND 
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FIG NO: 49 C13 NMR SPECTRUM FOR ISOLATED COMPOUND 
 
 
GC-MS ANALYSIS 
The compound present in the ethanolic extract were identified by GC-MS analysis. 
The active principles with their retention time (RT), molecular formula, molecular 
weight (MW) and concentration (%) in the ethanol extract is listed as follows.  
Retention time  33.33 
Molecular formula C30H50O 
Molecular weight  426.73 
Peak area % 68.14% 
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FIG NO: 50 GC-MASS SPECTRUM FOR ISOLATED  
 
CONCLUSION FOR ISOLATION 
                Based on the physical, chemical properties and the spectral studies such as 
IR, NMR and GC-MS results the isolated compound was found to be lupeol. The 
isolated lupeol was compared with that of standard lupeol. This lupeol is considered 
to be responsible for the pharmacological actions. 
 
FIG N0: 51 STRUCTURE OF ISOLATED COMPOUND 
SF1 Base=68.96%   RT=33.33 
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12. SUMMARY AND CONCLUSION 
 
          Among the world wide population arthritis affects 15% of people. The 
prevalence of arthritis is increasing throughout the world. In recent years, 
ethnobotanical and traditional uses of phytoconstituents from plant origin received 
much attention as they are very effective and safe for human use. Man was 
completely depending on the natural medicine because of reduced side effects. Herbal 
medicine is a major component in all indigenous traditional medicine and a common 
element in Ayurveda, Siddha, Homeopathy and Naturopathy systems of medicine. 
Hence the present study is an attempt to evaluate the anti-arthritic activity on the bark 
of Sterculia foetida Linn.,  
 
PHARMACOGNOSTICAL STUDIES  
          The pharmacognostical studies on the bark of Sterculia foetida Linn., was 
carried out, which showed the unique features of the bark which is used to 
differentiate it from other species.   
 
          Macroscopical studies states the characteristic features of bark like grey 
colour, smooth in outer and fibrous in inside, single quill and smooth texture. 
 
          The anatomical studies of the bark showed the presence of cork, cortex, 
sclerides, phloem and medullary rays. 
 
          Powder analysis of the bark showed the presence of parenchyma, fibers, 
sclerides, calcium oxalate crystals, etc,. 
 
 Physiochemical studies various physiochemical constants were evaluated 
such as ash values, extractive values, foreign organic matter, foaming index, swelling 
index and loss on drying. 
 
         These pharmacognostical parameters evaluated are useful for the establishment 
of standards of bark which is essential for its identity and purity. 
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Phytochemical studies 
         In phytochemical study, the powdered bark is successively extracted with n-
hexane, chloroform, ethyl acetate and ethanol by using soxhlet apparatus. 
 
          Preliminary phytochemical investigation was done for the powdered bark 
and all the extracts. It was found to contains flavonoids, triterpenoids, alkaloids, 
phenolic compounds, steroids, etc,. 
 
         Quantitative estimation of the phytoconstituents is carried out for alkaloids, 
steroids, phenolic compounds and flavonoids. 
 
          Fluorescence analysis was done to find out characteristic fluorescent substance 
present in the powdered bark and all the extracts, and no fluorescent substance was 
found. 
 
         High performance thin layer chromatography (HPTLC) was performed with 
ethanolic extract of bark of Sterculia foetida Linn., and the finger print showed the 
presence of 12 peaks helpful in the quantitative and qualitative identification of 
phytoconstituents of Sterculia foetida Linn., bark. 
 
In vitro studies 
         All the extracts were subjected to in-vitro antioxidant activity and in-vitro anti-
arthritic activity. The ethanolic extract showed the maximum antioxidant potential 
and maximum inhibition in the protein denaturation method. Hence the ethanolic 
extract was chosen for the in-vivo studies. 
 
Pharmacological activity 
          Acute toxicity studies were carried out in the Wistar albino rats as per the 
OECD guidelines. The Ethanol extract was found to be safe up to the dose of 
2000mg/kg. Therefore 1/10th of the dose (200mg/kg) and 1/20th of the dose 
(400mg/kg) were selected. 
 
         In-vivo anti-arthritic activity was carried out for ethanolic extract in Wistar 
albino rats by using complete freund’s adjuvant induced arthritis model. Ethanolic 
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extract of dose 200 and 400mg/kg. were given orally to the rats. It is compared with 
standard Diclofenac sodium. Various parameters were studied for the evaluation of 
anti-arthritic activity. The ethanolic extract at the dose 400mg/kg. showed significant 
anti-arthritic effect on the arthritis induced rats which was comparable with that of the 
standard.  
 
Isolation and Identification of Lupeol 
         The Lupeol was isolated by column chromatography method and identified by 
spectral analysis such as IR, NMR and GC-MS methods. The lupeol is pentacyclic tri 
terpenoid derivative which is having anti-inflammatory and anti-arthritic effect. 
Hence the isolated compound lupeol was considered to be responsible of 
pharmacological actions. 
CONCLUSION 
         From the above studies it can be concluded that the Pharmacognostical 
standards generated will be useful for the proper identification of the plant that could 
be made use of, those who deal with the species and also in the quality assurance of 
the plant species with the support of Phytochemical and in-vitro Pharmacological 
studies, ethanolic extract was selected and subjected to in-vivo anti-arthritic activity. 
The ethanolic extract at the dose of 400mg/kg showed significant anti-arthritic 
activity which was comparable with that of the standard. Lupeol was isolated from the 
ethanolic extract and identified by spectral studies. 
          Further studies are focused on in-vivo pharmacological activity of isolated 
compound and its structural activity relationship. 
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